 |
|
|
 | Elan Corp PLC (NYSE:ELN) | 2/8/2010 |  |
| THURSDAY, FEBRUARY 04, 2010 | | 12:45 PM | Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research - PR Newswire |  | | MONDAY, FEBRUARY 01, 2010 | | 10:38 AM | INFOSYS TECHNOLOGIES: Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research - M2 |  | | FRIDAY, JANUARY 29, 2010 | | 10:36 AM | BiomedReports: News and FDA Updates for Cytori (NASDAQ:CYTX), Elan (NYSE:ELN), Enzon (Nasdaq:ENZN) - M2 |  | | THURSDAY, JANUARY 28, 2010 | | 10:23 AM | BiomedReports: News and FDA Updates for Cytori (NASDAQ:CYTX), Elan (NYSE:ELN), Enzon (Nasdaq:ENZN) - M2 |  | | WEDNESDAY, JANUARY 27, 2010 | | 4:15 PM | Elan Announces Webcast of Fourth Quarter and Full Year 2009 Financial Results - BusinessWire |  | | MONDAY, JANUARY 25, 2010 | | 2:00 AM | Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA(TM) (Dalfampridine) Extended Release Tablets - BusinessWire |  | | FRIDAY, JANUARY 22, 2010 | | 4:53 PM | Acorda Therapeutics Announces FDA Approval of AMPYRA(TM) (dalfampridine) to Improve Walking in People with Multiple Sclerosis -- Demonstrated by Increases in Walking Speed - BusinessWire |  | | MONDAY, JANUARY 11, 2010 | | 8:00 AM | World-Renowned Yogi Baron Baptiste Unveils New Program to Help People with Multiple Sclerosis - BusinessWire |  | | TUESDAY, JANUARY 05, 2010 | | 5:33 PM | Elan to Present at the 2010 J.P. Morgan Healthcare Conference - BusinessWire |  | | THURSDAY, DECEMBER 17, 2009 | | 12:54 PM | Aeolus Pharmaceuticals' AEOL 11207 Subject of Research Grant from Michael J. Fox Foundation - BusinessWire |  |
|
|
 |